Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autosomal-Dominant Bestrophinopathy”

2 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 2 of 2 results

Testing effectiveness (Phase 2)Looking for participantsNCT07185256
What this trial is testing

Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)

Who this might be right for
ARBBVMDAutosomal-Dominant Bestrophinopathy+1 more
Opus Genetics, Inc 10
Not applicableStudy completedNCT02162953
What this trial is testing

Stem Cell Models of Best Disease and Other Retinal Degenerative Diseases.

Who this might be right for
Retinal DiseaseBestrophinopathyBest Vitelliform Macular Dystrophy+2 more
Mayo Clinic 48